ASN and FDA: Recognizing Ways to Increase Diversity in Clinical Trials ~ ASN Podcast

ASN Executive Vice President, Tod Ibrahim and ASN Past President,
Jonathan Himmelfarb, MD, FASN, speak with Jonca Bull, MD and
Patrick Archdeacon, MD from the FDA about ways to improve
disparities in clinical trials.

ASN and FDA: Recognizing Ways to Increase Diversity in Clinical Trials

Beschreibung

Weitere Episoden

nephSAP Guest Editor Interview: Racial Inequalities in Access to Kidney Transplantation: New Challenges, New Solutions to a Decades-Old Problem

IOTA, Transplant Policy, and End-of-Year Legislation: What You Need to Know (Policy Update December 2024)

Election Outcomes and Renal Realities: The Future of Kidney Care Under New Presidential Leadership (Policy Update November 2024)

Post-Kidney Week Policy Update (October 2024)

New Series: nephSAP Guest Editor Interview: Chronic Kidney Disease Coming of Age

Kommentare (0)

Abonnenten

Anmelden mit